Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01461473 · ClinicalTrials.gov registry record · NA
Comparative Outcomes Management With Electronic Data Technology (COMET) Study
A NA study of Sleep Apnea, Obstructive, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 131
- Enrollment target
- 4
- Study locations
NCT01461473: Completed NA study of Sleep Apnea, Obstructive, sponsored by Stanford University.
NCT01461473 is a NA study of Sleep Apnea, Obstructive that has completed, run by Stanford University. The registered enrollment target is 131 participants, below the 259-participant average among 45 other Sleep Apnea, Obstructive trials with a reported enrollment target (49% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01461473, a NA study of Sleep Apnea, Obstructive, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 131 participants
- Enrollment target
- 4
- Study locations
Study Summary
STAGE I of the COMET study was to develop an Electronic Network Informatics Infrastructure that prospectively enabled access to and the sharing of clinical and research data. STAGE II: This was a Comparative Effectiveness Trial (CET) evaluating positive airway pressure (PAP) vs. oral appliance (OA) therapy in improving hypertension and abnormalities in cardiovascular function in overweight/obese patients with obstructive sleep apnea (OSA). Data collected during the STAGE II study was incorporated in Part 3 of the STAGE I study. STAGE III of the COMET study was completion of data analysis and preparation of the electronic network informatics infrastructure for use beyond the four Clinical Centers to interested CTSA institutions. We also explored expanding ontologies, and the use of federated database methodology.
Primary Outcome
Mean arterial blood pressure during the sleep period as recorded by 24-hour ambulatory blood pressure monitoring after approximately 2 months of treatment
Conditions Studied
Interventions
- DEVICE Positive Airway Pressure (PAP)
- DEVICE Oral Appliance (OA)
Study Locations (4)
California
- Stanford Sleep Medicine Center - Redwood City
Massachusetts
- Harvard Brigham and Women's Hospital - Boston
Pennsylvania
- Center for Sleep and Circadian Neurobiology, University of Pennsylvania School of Medicine - Philadelphia
Wisconsin
- University of Wisconsin-Madison School of Medicine, Department of Psychiatry - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 131 participants |
| Start Date | 2011-12 |
| Est. Completion | 2014-06 |
| Phase | NA |
What the finished NCT01461473 record still lists
NCT01461473 is an interventional study that assigns participants to a tested intervention. The registered 131 participants enrollment target is mid-sized for trials with a published cap, below the 259-participant average among 45 other Sleep Apnea, Obstructive trials with a reported enrollment target (49% lower).
The record links to 1 condition, with Sleep Apnea, Obstructive appearing as the primary indexed condition, and to 2 interventions - of which Positive Airway Pressure (PAP) is the first listed.
NCT01461473 reports a single indexed study location in California, Massachusetts, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01461473 about?
NCT01461473 is a clinical study titled "Comparative Outcomes Management With Electronic Data Technology (COMET) Study". STAGE I of the COMET study was to develop an Electronic Network Informatics Infrastructure that prospectively enabled access to and the sharing of clinical and research data. STAGE II: This was a Comparative Effectiveness Trial (CET) evaluating positive airway pressure (PAP) vs. oral appliance (OA)...
What is the current status of trial NCT01461473?
This trial is currently completed. It is a NA study. The enrollment target is 131 participants. The study started on 2011-12. Estimated completion is 2014-06.
What conditions does trial NCT01461473 study?
This clinical trial studies the following conditions: Sleep Apnea, Obstructive.
What interventions are being tested in trial NCT01461473?
The interventions under investigation include: Positive Airway Pressure (PAP) (DEVICE), Oral Appliance (OA) (DEVICE).
Who is sponsoring clinical trial NCT01461473?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01461473 being conducted?
This trial has 4 study locations across California, Massachusetts, Pennsylvania, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sleep Apnea, Obstructive
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01461473's enrollment target sits among peer trials
131 15th of 45 higher than 31 of 45 other Sleep Apnea, Obstructive trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sleep Apnea, Obstructive trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The PREDICTOR Study: Assessing Diagnostic Predictors of Airway Collapse in Patients With Obstructive Sleep Apnea
RECRUITING · NA
-
Home Apnea Testing in CHildren Trial
RECRUITING · NA
-
Lateral Pharyngoplasty Outcomes in Children Undergoing Tonsillectomy
RECRUITING · NA
-
The REPOSE (Reach for Equity in Pediatric Sleep Evaluation) Navigation Intervention
RECRUITING · NA
-
Type 1 Diabetes and Obstructive Sleep Apnea
RECRUITING · NA
-
NPA-OSA Device Tolerability, Usability and Acclimation Clinical Study in Adult Obstructive Sleep Apnea (OSA) Patients
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03051464 · 131 participants · Phase 2
No Surgery Trial / Two Dose-escalation Strategies
- NCT04301843 · 131 participants · Phase 2
Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma
- NCT04748549 · 131 participants · NA
Intraoperative VR for Older Patients Undergoing TKA
- NCT05951179 · 131 participants · Phase 2
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia